Coronavirus In Minnesota: HealthPartners Begins Clinical Trial For Drug To Treat COVID-19 Pneumonia Patients
The drug - called CM4620-IE - received fast-track approval from the FDA earlier this month, allowing HealthPartners to begin clinical trials.